Skip To Content

AHRO Masterclass in Pharmacovigilance

Time limit: 90 days
20 credits

Sorry! The enrollment period is currently closed. Please check back soon.

Full course description



Course Outcome 

After the course, participants should be able to: 

  • Describe various type of data and how they are used  
  • Describe confidence interval and p-values 
  • Describe how to identify information to perform basic sample size calculation 
  • Describe and interpret simple analysis 
  • Define correlation and simpler linear regression 
  • Understand the value and opportunities of data 
  • Describe randomisation, blocking and power calculations 


Course Modules 

  • Preclinical Development to IND 
  • The Economic Perspective 
  • Drug Research & Development 
  • Benefit-risk assessment in drug development 
  • Drug Development, Approval, and Safety 
  • Drug Safety in Pre- and post approval phases.


Teaching: The course will be taught through series of online tutorials, online formative exercises, series of podcasts and discussion forums. It is compulsory that student take part in 90% of online tutorials Self-directed learning is an essential component of this training. Electronic learning resources will be made available in our VLE.  


Learning breakdown: Our online courses combine several elements to create a balanced blend of learning. Learners will be able to learn at their own pace during the week by viewing content, engaged in discussions, and completing assignments. It is expected that on the average, 8 to 10 hours per week is required for a course. 


Assessment:  Assessment for this course is based on summative assessment which counts to the module mark. Each summative assessment for a module will be made of 1000 word essays, scientific article of high standard, 15 minutes presentations, and 3000 worded final assignment. 


Duration: 12 weeks 


Commitment: 8-10 hours per week as follows: 




Projected time (Hours) 


Interactive learning 








Self-guided Research/Learning 




Live sessions 




Eligibility: The course is designed for professionals who want to improve their skills and understanding of pharmacovigilance in clinical trials.